Insiders Updates
Negative sentiment towards GALT reflected in surge in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
In a filing, Galectin Therapeutics Inc revealed its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21